Tito R Mendoza
Overview
Explore the profile of Tito R Mendoza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
5827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mendoza T, Hong D, Peterson C, Stephen B, Dumbrava E, Pant S, et al.
Sci Rep
. 2022 Aug;
12(1):14367.
PMID: 35999229
Patients with rare solid tumors treated on early phase trials experience toxicities from their tumors and treatments. However, limited data exist to describe the detailed symptom burden suffered by these...
12.
Sheshadri A, Goizueta A, Shannon V, London D, Garcia-Manero G, Kantarjian H, et al.
Cancer
. 2022 Apr;
128(14):2736-2745.
PMID: 35452134
Background: Immune checkpoint inhibitors (ICI), combined with hypomethylating agents, can be used to treat acute myeloid leukemia (AML), but this strategy results in a high rate of pneumonitis. The authors...
13.
Novotny P, Dueck A, Satele D, Frost M, Beebe T, Yost K, et al.
Clin Trials
. 2022 Jan;
19(3):307-315.
PMID: 35088616
Background: In clinical trials and clinical practice, patient-reported outcomes are almost always assessed using multiple patient-reported outcome measures at the same time. This raises concerns about whether patient responses are...
14.
Tan N, Nishi S, Lowenstein L, Mendoza T, Lopez-Olivo M, Crocker L, et al.
Cancer Med
. 2021 Dec;
11(3):790-797.
PMID: 34964284
Background: Professional organizations recommend the use of shared decision-making (SDM) in supporting patients' decisions about lung cancer screening (LCS). The objective of this study was to assess the impact of...
15.
Smith G, Mendoza T, Lowenstein L, Shih Y
J Natl Cancer Inst Monogr
. 2021 Sep;
2021(57):10-14.
PMID: 34478512
Cancer-related financial hardship is highly prevalent and affects individuals in the setting of cancer care delivery across the survivorship trajectory. Mitigating financial hardship requires multi-level solutions at the policy, payer,...
16.
17.
Wang X, Shi Q, Mendoza T, Garcia-Gonzalez A, Chen T, Kamal M, et al.
Support Care Cancer
. 2021 Apr;
29(10):6099-6107.
PMID: 33792800
Background: Patients with multiple myeloma (MM) experience substantial cancer/treatment-related symptom burden during maintenance therapy. This is a phase II randomized, double-blinded, placebo-controlled clinical trial to examine the effect of minocycline...
18.
Wu J, Yuan Y, Long Priel D, Fink D, Peer C, Sissung T, et al.
Clin Cancer Res
. 2021 Mar;
27(12):3298-3306.
PMID: 33785481
Purpose: To investigate the toxicity profile and establish an optimal dosing schedule of zotiraciclib with temozolomide in patients with recurrent high-grade astrocytoma. Patients And Methods: This two-stage phase I trial...
19.
Alshawa A, Cadena A, Stephen B, Reddy A, Mendoza T, McQuinn L, et al.
Invest New Drugs
. 2021 Feb;
39(4):1113-1122.
PMID: 33580845
Purpose Acute radiation-induced esophagitis (ARIE) leads to treatment delays, decreased quality of life (QOL), and secondary adverse events such as weight loss. Grade 3 ARIE occurs in 15%-30% of patients...
20.
Nishi S, Lowenstein L, Mendoza T, Lopez Olivo M, Crocker L, Sepucha K, et al.
Chest
. 2021 Feb;
160(1):330-340.
PMID: 33556362
Background: Lung cancer screening (LCS) reduces lung cancer mortality, but it also carries a range of risks. Shared decision-making (SDM) is a process of engaging patients in their health care...